Assignee
NEURODERM LTD
IL·48 granted patents·42 pending applications·393 citations·filing 2000–2024
Top patents by PatentIndex Score
90 records- 0196US10258585B2DOPA decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2017·Granted Apr 16, 2019·8 cites·18 claims
- 0296US7863336B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2010·Granted Jan 4, 2011·27 cites·11 claims
- 0395US10813902B2DOPA decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2019·Granted Oct 27, 2020·5 cites·24 claims
- 0495USD887577SVial adapterNEURODERM LTD·Filed 2018·Granted Jun 16, 2020·54 cites·1 claims
- 0595US10624839B2Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2018·Granted Apr 21, 2020·6 cites·10 claims
- 0695US10603430B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Mar 31, 2020·22 cites·26 claims
- 0795US10463787B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Nov 5, 2019·22 cites·21 claims
- 0894US10463572B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2019·Granted Nov 5, 2019·20 cites·20 claims
- 0994US9993451B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2015·Granted Jun 12, 2018·9 cites·15 claims
- 1094US9040590B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·13 cites·17 claims
- 1194US9040578B2Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·15 cites·23 claims
- 1293US11779697B2Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2023·Granted Oct 10, 2023·3 cites·5 claims
- 1393US9381249B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2015·Granted Jul 5, 2016·11 cites·21 claims
- 1493US9040589B2Continuous administration of dopa decarboxylase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·11 cites·21 claims
- 1593US9040577B2Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2014·Granted May 26, 2015·12 cites·21 claims
- 1691US11331293B1Method for treatment of Parkinson's diseaseNEURODERM LTD·Filed 2022·Granted May 17, 2022·3 cites·15 claims
- 1791US11213502B1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2021·Granted Jan 4, 2022·5 cites·8 claims
- 1891US10022320B2Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2015·Granted Jul 17, 2018·8 cites·4 claims
- 1990US11458115B2Method for treatment of Parkinson's diseaseNEURODERM LTD·Filed 2022·Granted Oct 4, 2022·2 cites·30 claims
- 2089US2025114315A1Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for sameNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2188US6746688B1Apparatus for the transdermal treatment of Parkinson's diseaseNEURODERM LTD·Filed 2000·Granted Jun 8, 2004·47 cites·2 claims
- 2286US2025073193A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2385US2025177292A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 2485US2023321019A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2022·Application pending·0 cites
- 2583USD985031SBushingNEURODERM LTD·Filed 2021·Granted May 2, 2023·8 cites·1 claims
- 2683USD935478SDisplay screen with graphical user interfaceNEURODERM LTD·Filed 2020·Granted Nov 9, 2021·7 cites·1 claims
- 2782US10525134B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2017·Granted Jan 7, 2020·2 cites·16 claims
- 2881US2023047523A1Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2022·Application pending·0 cites
- 2980USD868689SPump device and charging station setNEURODERM LTD·Filed 2018·Granted Dec 3, 2019·18 cites·1 claims
- 3080US2025325506A1Method of treatment of parkinson’s diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 3179USD921190SPump deviceNEURODERM LTD·Filed 2018·Granted Jun 1, 2021·17 cites·1 claims
- 3279US2023240980A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3379US2023096364A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3477USD1098906SNutNEURODERM LTD·Filed 2024·Granted Oct 21, 2025·0 cites·1 claims
- 3577US2023047847A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2022·Application pending·0 cites
- 3676US2025152534A1Method of treatment of parkinson’s diseaseNEURODERM LTD·Filed 2024·Application pending·0 cites
- 3774USD960905SDisplay screen with graphical user interfaceNEURODERM LTD·Filed 2021·Granted Aug 16, 2022·3 cites·1 claims
- 3874US2021077442A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2020·Application pending·0 cites
- 3973USD1032831SSnap fit plunger release memberNEURODERM LTD·Filed 2022·Granted Jun 25, 2024·4 cites·1 claims
- 4073US9999674B2Compositions comprising apomorphine and organic acids and uses thereofNEURODERM LTD·Filed 2013·Granted Jun 19, 2018·1 cites·14 claims
- 4172US2020397730A1Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4272US2021000777A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4371USD921189SPump device portion with vial adaptersNEURODERM LTD·Filed 2018·Granted Jun 1, 2021·12 cites·1 claims
- 4471US2023064357A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2022·Application pending·0 cites
- 4569USD1039138SSnap fit plunger rodNEURODERM LTD·Filed 2022·Granted Aug 13, 2024·3 cites·1 claims
- 4669US2021093560A1Method for treatment of parkinson's diseaseNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4768USD1032833SBayonet plunger release memberNEURODERM LTD·Filed 2022·Granted Jun 25, 2024·3 cites·1 claims
- 4868US2021038505A1Dopa decarboxylase inhibitor compositionsNEURODERM LTD·Filed 2020·Application pending·0 cites
- 4968US2019125708A1Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for SameNEURODERM LTD·Filed 2018·Application pending·0 cites
- 5067US2023123806A1Device for subcutaneous delivery of fluid medicamentNEURODERM LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NEURODERM LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →